A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

<p>Abstract</p> <p>Background</p> <p>Pegylated liposomal doxorubicin (PLD) is active in metastatic breast cancer. This observational study evaluated the efficacy and safety of PLD in patients treated during routine clinical practice.</p> <p>Methods</p>...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wischnik Arthur, Schmidt Marcus, Neise Michael, Nusch Arnd, Fett Werner, Huober Jens, Gerhardt Steffen, Goehler Thomas, Lück Hans-Joachim, Rost Andreas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2010-01-01
Seri Bilgileri:BMC Cancer
Online Erişim:http://www.biomedcentral.com/1471-2407/10/2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller